Sickle Cell Disease Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies – Sanofi, Glycomimetics, Global Blood Therapeutics (GBT), CSL Behr

Advertisements
DelveInsight’s “Sickle Cell Disease Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Sickle Cell Disease, historical and forecasted epidemiology as well as the Sickle Cell Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Sickle Cell Disease market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Sickle Cell Disease pipeline products will significantly revolutionize the Sickle Cell Disease market dynamics.  

 

DelveInsight’sSickle Cell Disease Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Sickle Cell Disease, historical and forecasted epidemiology as well as the Sickle Cell Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. 

 

Sickle Cell Disease Overview

Sickle cell disease (SCD) is a group of inherited red blood cell disorder caused by a structural abnormality of hemoglobin called sickle hemoglobin (HbS) which encodes hemoglobin subunit β. HbS is inherited in an autosomal recessive way and can occur due to homozygosity for HbS (HbSS). HbS is functional and soluble when oxygenated, but upon deoxygenation, it polymerizes, leading to the generation of deformed red blood cells known as sickled cells and dense erythrocytes.

 

Sickle Cell Disease Symptoms  

The Sickle Cell Disease symptoms include – 

Anemia
Episodes of pain
Swelling of hands and feet
Frequent infections
Delayed growth or puberty
Vision problems

 

Some of the key facts of the Sickle Cell Disease Market Report

The Sickle Cell Disease market size is anticipated to grow with a significant CAGR during the study period (2019-2032)  
According to a study published by Sedrak and Kondamudi, sickle cell anemia is the most common monogenic disorder 
It is estimated that in the United States, the population of sickle cell disease is approximately 100,000, and likely to increase 
As per a study by Wastnedge et al, the global meta-estimate for the birth prevalence of homozygous sickle cell disease was 111.91 per 100 ,000 live births, and that for heterozygous sickle cell disease was 4229.72 per 100 ,000 
Key Sickle Cell Disease Companies: Sanofi, Glycomimetics, Global Blood Therapeutics (GBT), CSL Behring, and others 
Key Sickle Cell Disease Therapies: GMI-1687, Inclacumab, CSL889, BIVV003, and others 
The Sickle Cell Disease epidemiology based on gender analyzed that Sickle Cell Disease affects males and females equally

 

Get a Free sample for the Sickle Cell Disease Market Report

 

Key benefits of the Sickle Cell Disease Market report:

Sickle Cell Disease market report covers a descriptive overview and comprehensive insight of the Sickle Cell Disease Epidemiology and Sickle Cell Disease market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
The Sickle Cell Disease market report provides insights on the current and emerging therapies.
Sickle Cell Disease market report provides a global historical and forecasted market covering drug outreach in 7MM.
The Sickle Cell Disease market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Sickle Cell Disease market.

 

Discover more about therapies set to grab major Sickle Cell Disease market share @ Sickle Cell Disease market forecast

 

Sickle Cell Disease Epidemiology Segmentation:

The Sickle Cell Disease market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

Total Prevalence of Sickle Cell Disease
Prevalent Cases of Sickle Cell Disease by severity
Gender-specific Prevalence of Sickle Cell Disease
Diagnosed Cases of Episodic and Chronic Sickle Cell Disease 

 

Sickle Cell Disease Market  

The dynamics of the Sickle Cell Disease market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032. 

 

“Novel gene therapy candidates are being developed for the Sickle Cell Disease treatment include: CTX001(CRISPR Therapeutics/Vertex Pharma’s, and LentiGlobin BB305/Betibeglogene autotemcel (Bluebird Bio)”

 

Download the report to understand which factors are driving Sickle Cell Disease epidemiology trends @ Sickle Cell Disease Epidemiological Insights

 

Sickle Cell Disease Therapies

GMI-1687
Inclacumab
CSL889
BIVV003

 

Sickle Cell Disease Key Companies 

Sanofi
Glycomimetics
Global Blood Therapeutics (GBT)
CSL Behring

 

Scope of the Sickle Cell Disease Market Report

Study Period: 2019–2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan] Key Sickle Cell Disease Companies: Sanofi, Glycomimetics, Global Blood Therapeutics (GBT), CSL Behring, and others
Key Sickle Cell Disease Therapies: GMI-1687, Inclacumab, CSL889, BIVV003, and others
Therapeutic Assessment: Sickle Cell Disease current marketed and Sickle Cell Disease emerging therapies
Sickle Cell Disease Market Dynamics:  Sickle Cell Disease market drivers and barriers 
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Unmet Needs, KOL’s views, Analyst’s views, Sickle Cell Disease  Market Access and Reimbursement

 

Table of Contents 

1. Sickle Cell Disease Market Report Introduction

2. Executive Summary for Sickle Cell Disease

3. SWOT analysis of Sickle Cell Disease

4. Sickle Cell Disease Patient Share (%) Overview at a Glance

5. Sickle Cell Disease Market Overview at a Glance

6. Sickle Cell Disease Disease Background and Overview

7. Sickle Cell Disease Epidemiology and Patient Population

8. Country-Specific Patient Population of Sickle Cell Disease 

9. Sickle Cell Disease Current Treatment and Medical Practices

10. Sickle Cell Disease Unmet Needs

11. Sickle Cell Disease Emerging Therapies

12. Sickle Cell Disease Market Outlook

13. Country-Wise Sickle Cell Disease Market Analysis (2019–2032)

14. Sickle Cell Disease Market Access and Reimbursement of Therapies

15. Sickle Cell Disease Market drivers

16. Sickle Cell Disease Market barriers

17.  Sickle Cell Disease Appendix

18. Sickle Cell Disease Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

To know more about Sickle Cell Disease treatment, visit @ Sickle Cell Disease Medications

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Daily Digest Signup

Daily business and market business news, business management tips, market research insights, and more.

Advertisements

Smart public opinion research for everyone.

Generated by Feedzy
%d bloggers like this: